Next Article in Journal
Linezolid Resistance in Staphylococci
Next Article in Special Issue
NSAIDs and Cell Proliferation in Colorectal Cancer
Previous Article in Journal / Special Issue
Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(6), 1966-1987;

NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data

Department of Neurology, University of Szeged, Semmelweis u. 6. Szeged, Hungary H-6720, Hungary
Headache Research Unit, Department of Neurology & GIGA Neurosciences, Liège University, CHU-Sart Tilman, T4(+1), B36, B-4000 Liège, Belgium
Author to whom correspondence should be addressed.
Received: 27 April 2010 / Revised: 18 May 2010 / Accepted: 11 June 2010 / Published: 17 June 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
Full-Text   |   PDF [265 KB, uploaded 17 June 2010]   |  


Migraine is a common disabling neurological disorder with a serious socio-economical burden. By blocking cyclooxygenase nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the synthesis of prostaglandins, which are involved in the pathophysiology of migraine headaches. Despite the introduction more than a decade ago of a new class of migraine-specific drugs with superior efficacy, the triptans, NSAIDs remain the most commonly used therapies for the migraine attack. This is in part due to their wide availability as over-the-counter drugs and their pharmaco-economic advantages, but also to a favorable efficacy/side effect profile at least in attacks of mild and moderate intensity. We summarize here both the experimental data showing that NSAIDs are able to influence several pathophysiological facets of the migraine headache and the clinical studies providing evidence for the therapeutic efficacy of various subclasses of NSAIDs in migraine therapy. Taken together these data indicate that there are several targets for NSAIDs in migraine pathophysiology and that on the spectrum of clinical potency acetaminophen is at the lower end while ibuprofen is among the most effective drugs. Acetaminophen and aspirin excluded, comparative trials between the other NSAIDs are missing. Since evidence-based criteria are scarce, the selection of an NSAID should take into account proof and degree of efficacy, rapid GI absorption, gastric ulcer risk and previous experience of each individual patient. If selected and prescribed wisely, NSAIDs are precious, safe and cost-efficient drugs for the treatment of migraine attacks. View Full-Text
Keywords: migraine; NSAIDs; acetaminophen; aspirin; randomized controlled trials; experimental data migraine; NSAIDs; acetaminophen; aspirin; randomized controlled trials; experimental data

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Pardutz, A.; Schoenen, J. NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. Pharmaceuticals 2010, 3, 1966-1987.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top